Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚ฌ3.12 B
Marketcap
158,78ย โ‚ฌ
Share price
-1.93%
Change (1 day)
34.65%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): โ‚ฌ49.13 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.25 Billion. In 2024 the company made an earning of โ‚ฌ4.76 Million a decrease over its 2023 earnings that were of โ‚ฌ55.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ49.13 M930.56%
2024 โ‚ฌ4.76 M-91.37%
2023 โ‚ฌ55.24 M-7.59%
2022 โ‚ฌ59.77 M4%
2021 โ‚ฌ57.48 M296.42%
2020 โ‚ฌ14.49 M-97.97%
2019 โ‚ฌ0.71 B275.62%
2018 โ‚ฌ0.19 B237.48%
2017 โ‚ฌ56.39 M49.05%
2016 โ‚ฌ37.83 M55.41%
2015 โ‚ฌ24.34 M36.87%
2014 โ‚ฌ17.78 M29.59%
2013 โ‚ฌ13.72 M1309.35%
2012 โ‚ฌ0.97 M-43.97%
2011 โ‚ฌ1.73 M-113.19%
2010 -โ‚ฌ13.18 Million59.86%
2009 -โ‚ฌ8.25 Million-61.33%
2008 -โ‚ฌ21.33 Million-58.75%
2007 -โ‚ฌ51.69 Million20.52%
2006 -โ‚ฌ42.89 Million81.27%
2005 -โ‚ฌ23.66 Million
2003 -โ‚ฌ16.48 Million-20.6%
2002 -โ‚ฌ20.75 Million4.38%
2001 -โ‚ฌ19.88 Million-48.83%
2000 -โ‚ฌ38.84 Million-19.74%
1999 -โ‚ฌ48.39 Million-19.06%
1998 -โ‚ฌ59.78 Million126.71%
1997 -โ‚ฌ26.37 Million-5.83%
1996 -โ‚ฌ28.01 Million136.23%
1995 -โ‚ฌ11.86 Million-33.97%
1994 -โ‚ฌ17.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.08 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.15 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ8.00 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ19.83 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.32 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.24 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA